Matches in Nanopublications for { ?s ?p "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP400920.RAAuRMzHkD7SzP-biYrxy2ASkkklP6b0T8E_YAsZzORWE130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400920.RAAuRMzHkD7SzP-biYrxy2ASkkklP6b0T8E_YAsZzORWE130_provenance.
- NP753995.RAETftuf4A6MMkQ4s9s1yPyTR1iy72UcCarW-pOPeqdtw130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753995.RAETftuf4A6MMkQ4s9s1yPyTR1iy72UcCarW-pOPeqdtw130_provenance.
- NP419793.RAC4ahTRwxFID7fTwEhEOC1GyKp7-3ehHfWbXMiYyre_8130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419793.RAC4ahTRwxFID7fTwEhEOC1GyKp7-3ehHfWbXMiYyre_8130_provenance.
- NP435833.RAxhsQvE5w5vEs6qZaW4VkqDlZGmxhd7786coDJyZ6wlI130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435833.RAxhsQvE5w5vEs6qZaW4VkqDlZGmxhd7786coDJyZ6wlI130_provenance.
- NP435967.RAX6OxWjB_4vOrOIp2wAww3rpISd5uAU4JF6b8KHq7-Bw130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435967.RAX6OxWjB_4vOrOIp2wAww3rpISd5uAU4JF6b8KHq7-Bw130_provenance.
- NP419655.RAIoNxfz6YcMPzPb47pc7aL_GciOSFDzF2UYeDqbO6Pjw130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419655.RAIoNxfz6YcMPzPb47pc7aL_GciOSFDzF2UYeDqbO6Pjw130_provenance.
- NP355049.RAq9Imk9yWXeUVaZ94JSW0luGUHs8-lVEO9x1SdL5OjuM130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355049.RAq9Imk9yWXeUVaZ94JSW0luGUHs8-lVEO9x1SdL5OjuM130_provenance.
- NP355198.RAlSmgV7IdgN1uWKDw8eJmpM-v1dKxGBMbcbLNKp3k14Y130_assertion description "[Finally, validation of novel upregulated targets (CXCL1 and 3, GATA6, and DMBT1) in a larger independent panel of samples confirms the utility of integrative analysis in cancer biomarker discovery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355198.RAlSmgV7IdgN1uWKDw8eJmpM-v1dKxGBMbcbLNKp3k14Y130_provenance.